Spinal Cord Injury at C5-C7 Level
7
3
3
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (7)
Multi-functional Neuroprosthetic System for Restoration of Motor Function in Spinal Cord Injury
Grasp-Release Assessment of a Networked Neuroprosthesis Device
Individual Patient Expanded Access IND of Hope Biosciences Autologous Adipose-derived Mesenchymal Stem Cells for Treatment of SCI
Neuromodulation With Spinal Stimulation Methods
Brain Plus Spinal Stimulation for Cervical SCI
Nerve Transfer Surgery to Restore Upper-limb Function After Cervical Spinal Cord Injury
Cognitive Rehabilitation and FES for Hand Functionality in Persons With Cervical Spinal Cord Injury